-+ 0.00%
-+ 0.00%
-+ 0.00%

KODIAK SCIENCES ANNOUNCES FIRST PATIENTS ENROLLED IN GLOBAL PHASE 3 ALTO TRIAL OF KSI-501 IN PATIENTS WITH DIABETIC MACULAR EDEMA

Reuters·08/10/2026 20:43:53

Please log in to view news